Innocenti D.
- Country
- France
- Department
- HGE
Research Overview
- Phase III Randomized Study of Induction Chemotherapy with Modified DCF Regimen Followed by Chemoradiotherapy vs. Standard Chemoradiotherapy in Locally Advanced Anal Squamous Cell Carcinoma
- Phase III Multicentric Study on Chemotherapy Efficacy in Stage III Colorectal Cancer with Positive ctDNA Post-Surgery Using Irinotecan and Drug Combination
Data & Insights
Has run more than one trial at 47 of 158 partner sites.
Specializations
Colorectal Cancer Research
The investigator specializes in stage III colorectal cancer treatment approaches, with particular emphasis on minimal residual disease detection and management. Their research encompasses post-surgical treatment strategies and circulating tumor DNA (ctDNA) analysis.
- Advanced Colon Carcinoma
- Disease Recurrence Monitoring
- Post-operative Care
Their work focuses on optimizing treatment outcomes through innovative monitoring techniques in colorectal cancer care.
Anal Cancer Therapeutics
The investigator concentrates on treating locally advanced anal squamous cell carcinoma, exploring innovative therapeutic combinations. Their expertise extends to multimodal treatment approaches incorporating both chemotherapy and radiotherapy.
- Advanced Anal Cancer Management
- Combined Treatment Modalities
- Induction Chemotherapy Protocols
Their research interests include evaluating treatment sequences in locally advanced anal cancer.
Gastrointestinal Oncology
The investigator demonstrates expertise in gastrointestinal tract malignancies, with a focus on developing personalized treatment strategies. Their work encompasses both early-stage and advanced disease management.
- Treatment Optimization
- Disease Surveillance
- Therapeutic Innovation
Their research addresses comprehensive care approaches in gastrointestinal oncology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.